| 1 |
Elham Assareh, Mohammad Amin Abbasi, Mahsa Heidari, S. Mohsen Asghari. A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics. Iran J Sci 2023. [ DOI: 10.1007/s40995-022-01400-8] [Reference Citation Analysis]
|
| 2 |
Sadeghdoust M, Aligolighasemabadi F, Dehesh T, Taefehshokr N, Sadeghdoust A, Kotfis K, Hashemiattar A, Ravandi A, Aligolighasemabadi N, Vakili O, Grabarek B, Staszkiewicz R, Łos MJ, Mokarram P, Ghavami S. The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in COVID-19 Patients with Diabetes Mellitus: A Longitudinal Multicenter Study. Arch Immunol Ther Exp (Warsz) 2023;71:8. [PMID: 36853269 DOI: 10.1007/s00005-023-00672-1] [Reference Citation Analysis]
|
| 3 |
Nainwal N. Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities. Pulm Pharmacol Ther 2022;77:102170. [PMID: 36240985 DOI: 10.1016/j.pupt.2022.102170] [Reference Citation Analysis]
|
| 4 |
Batineh Y, Al Khames Aga QA, Faris Nassir K, I Sulaiman T, Al-gharawi AA, I Rasheed J, Al Madfai Z, Sheikh Salem MA, Al Khames Aga LA, Rijab Agha MY, Abdullah E. Fenofibrate and Statins in Patients with COVID-19. RJPT 2022. [DOI: 10.52711/0974-360x.2022.00863] [Reference Citation Analysis]
|
| 5 |
Lao US, Law CF, Baptista-Hon DT, Tomlinson B. Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients. J Clin Med 2022;11:5454. [PMID: 36143101 DOI: 10.3390/jcm11185454] [Reference Citation Analysis]
|
| 6 |
Bakillah A, Hejji FA, Almasaud A, Jami HA, Hawwari A, Qarni AA, Iqbal J, Alharbi NK. Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells. Nutrients 2022;14:3417. [PMID: 36014919 DOI: 10.3390/nu14163417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Falcinelli E, Petito E, Gresele P. The role of platelets, neutrophils and endothelium in COVID-19 infection. Expert Rev Hematol 2022. [PMID: 35930267 DOI: 10.1080/17474086.2022.2110061] [Reference Citation Analysis]
|
| 8 |
Behrouj H, Vakili O, Sadeghdoust A, Aligolighasemabadi N, Khalili P, Zamani M, Mokarram P. Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19). Biochemistry and Biophysics Reports 2022;30:101264. [DOI: 10.1016/j.bbrep.2022.101264] [Reference Citation Analysis]
|
| 9 |
Zota IM, Stătescu C, Sascău RA, Roca M, Anghel L, Maștaleru A, Leon-Constantin MM, Ghiciuc CM, Cozma SR, Dima-Cozma LC, Esanu IM, Mitu F. Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness-A Narrative Review. Life (Basel) 2022;12. [PMID: 35743812 DOI: 10.3390/life12060781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Ting CT, Chen BS. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. Int J Mol Sci 2022;23:3649. [PMID: 35409008 DOI: 10.3390/ijms23073649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Kow CS, Hasan SS. The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs 2022;22:167-81. [PMID: 34341972 DOI: 10.1007/s40256-021-00490-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 12 |
Paskeh MDA, Entezari M, Clark C, Zabolian A, Ranjbar E, Farahani MV, Saleki H, Sharifzadeh SO, Far FB, Ashrafizadeh M, Samarghandian S, Khan H, Ghavami S, Zarrabi A, Łos MJ. Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868:166326. [DOI: 10.1016/j.bbadis.2021.166326] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 13 |
Kouhpeikar H, Khosaravizade Tabasi H, Khazir Z, Naghipour A, Mohammadi Moghadam H, Forouzanfar H, Abbasifard M, Kirichenko TV, Reiner Ž, Banach M, Sahebkar A. Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study. Front Cardiovasc Med 2022;9:820260. [DOI: 10.3389/fcvm.2022.820260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 14 |
Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyciński J, Lorzadeh S, Kotfis K, Ghavami S, Łos MJ. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Updat 2021;59:100794. [PMID: 34991982 DOI: 10.1016/j.drup.2021.100794] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 40.5] [Reference Citation Analysis]
|
| 15 |
Zuin M, Rigatelli G, Bilato C, Cervellati C, Zuliani G, Roncon L. Dyslipidaemia and mortality in COVID-19 patients: a meta-analysis. QJM 2021;114:390-7. [PMID: 33822215 DOI: 10.1093/qjmed/hcab071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 16 |
Umakanthan S, Senthil S, John S, Madhavan MK, Das J, Patil S, Rameshwaram R, Cintham A, Subramaniam V, Yogi M, Bansal A, Achutham S, Shekar C, Murthy V, Selvaraj R. The protective role of statins in COVID-19 patients: a retrospective observational study. Transl Med Commun 2021;6:22. [PMID: 34604534 DOI: 10.1186/s41231-021-00102-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Vahedian-Azimi A, Mohammadi SM, Banach M, Beni FH, Guest PC, Al-Rasadi K, Jamialahmadi T, Sahebkar A. Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis. Biomed Res Int 2021;2021:1901772. [PMID: 34568488 DOI: 10.1155/2021/1901772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 18 |
Karampoor S, Hesamizadeh K, Shams Z, Ghafari Novin A, Farahmand M, Zahednasab H, Mirzaei R, Zamani F, Hajibaba M, Bouzari B, Laali A, Tabibzadeh A, Hadi Karbalaie Niya M, Keyvani H. The role of lovastatin in the attenuation of COVID-19. Int Immunopharmacol 2021;101:108192. [PMID: 34607230 DOI: 10.1016/j.intimp.2021.108192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 19 |
Davoodi L, Jafarpour H, Oladi Z, Zakariaei Z, Tabarestani M, Ahmadi BM, Razavi A, Hessami A. Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial. Int J Cardiol Heart Vasc 2021;36:100875. [PMID: 34541293 DOI: 10.1016/j.ijcha.2021.100875] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 20 |
Ayeh SK, Abbey EJ, Khalifa BAA, Nudotor RD, Osei AD, Chidambaram V, Osuji N, Khan S, Salia EL, Oduwole MO, Yusuf HE, Lasisi O, Nosakhare E, Karakousis PC. Statins use and COVID-19 outcomes in hospitalized patients. PLoS One 2021;16:e0256899. [PMID: 34506533 DOI: 10.1371/journal.pone.0256899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 21 |
Diaz-Arocutipa C, Melgar-Talavera B, Alvarado-Yarasca Á, Saravia-Bartra MM, Cazorla P, Belzusarri I, Hernandez AV. Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients. Int J Infect Dis 2021;110:374-81. [PMID: 34375760 DOI: 10.1016/j.ijid.2021.08.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 22 |
Kumar V, Liu H, Wu C. Drug repurposing against SARS-CoV-2 receptor binding domain using ensemble-based virtual screening and molecular dynamics simulations. Comput Biol Med 2021;135:104634. [PMID: 34256255 DOI: 10.1016/j.compbiomed.2021.104634] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 23 |
Zein AFMZ, Sulistiyana CS, Khasanah U, Wibowo A, Lim MA, Pranata R. Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts. Postgrad Med J 2021:postgradmedj-2021-140409. [PMID: 34193549 DOI: 10.1136/postgradmedj-2021-140409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 24 |
Kollias A, Kyriakoulis KG, Kyriakoulis IG, Nitsotolis T, Poulakou G, Stergiou GS, Syrigos K. Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis. Atherosclerosis 2021;330:114-21. [PMID: 34243953 DOI: 10.1016/j.atherosclerosis.2021.06.911] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 25 |
Siri M, Dastghaib S, Zamani M, Rahmani-Kukia N, Geraylow KR, Fakher S, Keshvarzi F, Mehrbod P, Ahmadi M, Mokarram P, Coombs KM, Ghavami S. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses. Int J Mol Sci 2021;22:5992. [PMID: 34206057 DOI: 10.3390/ijms22115992] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 26 |
Pourriyahi H, Saghazadeh A, Rezaei N. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. J Neuroimmunol 2021;356:577578. [PMID: 33933818 DOI: 10.1016/j.jneuroim.2021.577578] [Reference Citation Analysis]
|
| 27 |
Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet 2021;304:5-38. [PMID: 33797605 DOI: 10.1007/s00404-021-06049-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 28 |
Wu CC, Lee AJ, Su CH, Huang CY, Islam MM, Weng YC. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. J Clin Med 2021;10:1450. [PMID: 33916281 DOI: 10.3390/jcm10071450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 29 |
Saghazadeh A, Rezaei N. Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19. Emergent Mater 2021;:1-20. [PMID: 33718777 DOI: 10.1007/s42247-021-00192-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Vahedian-Azimi A, Mohammadi SM, Heidari Beni F, Banach M, Guest PC, Jamialahmadi T, Sahebkar A. Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Arch Med Sci 2021;17:579-95. [PMID: 34025827 DOI: 10.5114/aoms/132950] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 31 |
Kouhpayeh HR, Tabasi F, Dehvari M, Naderi M, Bahari G, Khalili T, Clark C, Ghavami S, Taheri M. Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study. Transl Med Commun 2021;6:26. [PMID: 34805533 DOI: 10.1186/s41231-021-00106-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
